Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Berkman Charles S

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
OABIOmniAb, Inc.Berkman Charles SChief Legal OfficerApr 08, 2024Sale$5.276,95436,648292,617Apr 09, 2024, 06:37 PM
OABIOmniAb, Inc.Berkman Charles SChief Legal OfficerFeb 15, 2024Option Exercise$5.547,60942,154286,030Feb 20, 2024, 06:22 PM
OABIOmniAb, Inc.Berkman Charles SChief Legal OfficerJan 02, 2024Option Exercise$6.257,19544,969272,317Jan 03, 2024, 05:42 PM
OABIOmniAb, Inc.Berkman Charles SChief Legal OfficerDec 07, 2023Option Exercise$4.855,40326,205261,956Dec 11, 2023, 07:21 PM
OABIOmniAb, Inc.Berkman Charles SChief Legal OfficerFeb 15, 2023Option Exercise$3.809,54336,263381,509Feb 17, 2023, 07:50 PM
OABIOmniAb, Inc.Berkman Charles SSee RemarksDec 28, 2022Option Exercise$3.666,51823,856336,618Dec 30, 2022, 05:00 PM
OABIOmniAb, Inc.Berkman Charles SSee RemarksDec 01, 2022Option Exercise$3.3510,58035,443343,136Dec 05, 2022, 09:41 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryJan 26, 2022Option Exercise$113.682,156245,09433,298Jan 28, 2022, 08:42 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryFeb 15, 2021Option Exercise$172.461,015175,04728,701Feb 18, 2021, 06:28 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryFeb 04, 2021Sale$178.5018,0973,230,36928,906Feb 05, 2021, 05:03 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryJan 25, 2021Option Exercise$156.041,339208,94343,512Jan 27, 2021, 07:02 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryJun 30, 2020Option Exercise$89.0323821,18941,115Jul 01, 2020, 08:06 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryJun 04, 2020Sale$118.5911,1461,321,77140,877Jun 05, 2020, 04:07 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryFeb 15, 2020Option Exercise$97.2388185,66052,597Feb 18, 2020, 05:07 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryDec 20, 2019Option Exercise$105.871,131119,73949,069Dec 26, 2019, 02:01 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryAug 05, 2019Option Exercise$67.721,09374,01347,172Aug 06, 2019, 05:17 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryJun 28, 2019Option Exercise$97.0318217,65946,079Jul 02, 2019, 09:50 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryJan 10, 2019Option Exercise$65.622,850187,02939,913Jan 14, 2019, 09:17 AM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryDec 17, 2018Option Exercise$21.923,40074,52837,063Dec 17, 2018, 07:58 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryOct 24, 2018Option Exercise$16.793,90065,46233,663Oct 25, 2018, 05:44 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryOct 11, 2018Option Exercise$14.472,00028,94029,763Oct 12, 2018, 06:52 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretarySep 17, 2018Sale$175.535,626987,55130,576Sep 18, 2018, 06:16 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretarySep 04, 2018Option Exercise$162.4838,8346,309,85947,180Sep 05, 2018, 08:00 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryJun 29, 2018Option Exercise$117.8418021,21027,763Jul 03, 2018, 03:27 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryMar 06, 2018Option Exercise$165.8739265,02127,583Mar 06, 2018, 06:36 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SSVP, Gen. Counsel & SecretaryFeb 15, 2018Option Exercise$157.181,036162,83825,571Feb 16, 2018, 05:40 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryDec 28, 2017Option Exercise$138.661,175162,92626,095Dec 29, 2017, 09:16 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryAug 09, 2017Sale$126.9618,6252,364,66724,423Aug 10, 2017, 06:40 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryJun 30, 2017Option Exercise$87.1324321,17143,048Jul 05, 2017, 06:45 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryAug 05, 2016Option Exercise$83.5652,4144,379,62941,731Aug 09, 2016, 04:58 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryJul 10, 2015Sale$55.9228,1341,573,29740,521Jul 14, 2015, 07:35 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryJul 13, 2015Option Exercise$53.101,00053,10027,454Jul 14, 2015, 07:35 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryJun 30, 2015Option Exercise$45.6746521,23726,454Jul 01, 2015, 12:36 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryMar 16, 2015Sale$57.2716,528946,58830,119Mar 18, 2015, 04:32 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryDec 31, 2014Option Exercise$45.231265,69927,433Mar 18, 2015, 04:28 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryDec 31, 2014Buy$45.231265,69927,433Jan 05, 2015, 07:47 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryJun 30, 2014Buy$43.7932914,40827,307Jul 01, 2014, 12:16 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryMay 27, 2014Option Exercise$54.479,665526,44128,644May 28, 2014, 06:03 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryFeb 12, 2014Sale$45.3429,7621,349,41934,424Feb 14, 2014, 08:06 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryFeb 13, 2014Option Exercise$14.472,00028,94031,645Feb 14, 2014, 08:06 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryDec 31, 2013Buy$33.922097,08827,145Jan 02, 2014, 04:48 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryAug 30, 2013Option Exercise$30.4765,6542,000,15329,732Sep 04, 2013, 07:10 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryAug 16, 2013Option Exercise$26.3029,166766,97828,227Aug 20, 2013, 06:44 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryAug 19, 2013Option Exercise$10.054,28443,05417,928Aug 20, 2013, 06:44 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryJun 28, 2013Buy$17.3681514,14813,644Jul 01, 2013, 03:26 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryMay 10, 2013Sale$26.664,000106,64012,829May 13, 2013, 06:46 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretarySep 07, 2012Sale$18.774,24979,75414,329Sep 10, 2012, 01:55 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryJun 29, 2012Option Exercise$10.121,25012,65418,578Jul 03, 2012, 05:46 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryMar 08, 2012Sale$15.763,60656,83217,434Mar 08, 2012, 06:24 PM
LGNDDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryDec 30, 2011Option Exercise$10.091,23812,49115,934Jan 06, 2012, 05:19 PM
LGNDLIGAND PHARMACEUTICALS INCBerkman Charles SVP, Gen. Counsel & SecretaryFeb 16, 2011Sale$9.755,00048,75111,696Feb 18, 2011, 05:38 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe